HSPA5 and cancer: Cytoplasmic delivery of siRNA overcomes the problem of endosomal capture, leading to effective gene knockdown, chemotherapy sensitization, and cancer regression.[263] Previous studies suggest that the level of GRP78 is higher in sorafenib‐resistant cancer cells than sorafenib‐sensitive cells.